GENE ONLINE|News &
Opinion
Blog

2021-08-26| InterviewsSpecial

Current Challenges and Future Opportunities of Artificial RNA Editing – An Interview with Professor Toshifumi Tsukahara

by Kathy Huang
Share To
With two COVID-19 vaccines gaining emergency use approvals, mRNA technology has come into focus over the past year. RNA technology encompasses a wide range of modalities and RNA editing is one among them. Although the technique is still being perfected and hasn’t become clinically viable, its high efficiency and safety over DNA editing is expected to make a splash in the near future.

We interviewed Professor Toshifumi Tsukahara, an expert in RNA editing to know more about the current challenges and future opportunities in the field.

It's free! Log in now to read

LATEST
Vaccine Protecting Against 20 Different Pneumococcal Infections Proves Effective in Trial
2022-08-12
FDA Approves Roche’s Established Antiviral For Children Aged Five Or Older
2022-08-12
Novartis Reported Two Deaths Following Zolgensma Gene Therapy
2022-08-12
Extreme Climate Change Is Aggravating Infectious Diseases!
2022-08-11
In Response to Expanding Monkeypox Outbreak, FDA Approves Emergency Use of JYNNEOS Vaccine
2022-08-11
Potential $1 billion Acquisition of TeneoTwo by AstraZeneca comes to Fruition
2022-08-11
Gene Repair Therapy: First Patient Dosed With New Treatment for Sickle Cell Disease
2022-08-11
EVENT
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-20
Cell & Gene Therapy USA 2022
Virtual
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!